
Brian Gastman, MD, discusses results from a biomarkers analysis of patients with stage IIB/C melanoma in the phase 3 CheckMate76K trial.

Your AI-Trained Oncology Knowledge Connection!


Brian Gastman, MD, discusses results from a biomarkers analysis of patients with stage IIB/C melanoma in the phase 3 CheckMate76K trial.













Published: December 14th 2020 | Updated:

Published: December 14th 2020 | Updated:

Published: December 14th 2020 | Updated:

Published: December 14th 2020 | Updated:

Published: December 14th 2020 | Updated:

Published: December 14th 2020 | Updated: